Skip to content

Kinesiotaping Along with Mulligan's Mobilization with Movement in Adhesive Capsulitis

Effectiveness of Kinesiotaping Along with Mulligan's Mobilization with Movement on Improving Pain and Function in Patients with Adhesive Capsulitis of Shoulder: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06843057
Enrollment
30
Registered
2025-02-24
Start date
2022-01-05
Completion date
2022-08-11
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Capsulitis

Keywords

Rehabilitation, Manual Therapy, Exercise Therapy, Shoulder Pain

Brief summary

The study aimed to evaluate the effectiveness of combining Kinesiotaping with Mulligan's mobilization with movement in treating shoulder adhesive capsulitis. Thirty patients participated in a randomized control trial, divided equally into an experimental group and a control group. The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy, while the control group received only Mulligan's mobilization with movement and conventional physiotherapy. Pain, range of motion, and functional outcomes were measured using a visual analogue scale, goniometer, and the Shoulder Pain and Disability Index (SPADI) questionnaire.

Interventions

OTHERKinesio taping

Kinesio taping is a therapeutic technique that involves applying a special elastic tape to the skin to support and stabilize muscles and joints without restricting their range of motion.

OTHERMulligan's mobilization with movement techniques

Mulligan's mobilization with movement (MWM) techniques involve the application of a sustained manual force or glide to a joint while the patient actively performs a movement that is typically painful or restricted.

OTHERConventional physiotherapy

Mulligan Mobilization with Movement, Ultrasound Therapy, Active assisted ROM exercises for shoulder, Capsular Stretching exercises

Sponsors

King Saud University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Two Parallel Arms Experimental Design

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Primary adhesive capsulitis, * Controlled diabetes mellitus, * Restriction of movements in capsular pattern, * Shoulder pain for more than one month.

Exclusion criteria

* Secondary adhesive capsulitis, * Cancer, * Bilateral adhesive capsulitis, * Skin infections in the shoulder region, * Shoulder joint infections, * Wounds or ulcers in the shoulder region, * Hypersensitivity to tape, * Recent shoulder dislocation, * Recent shoulder fractures.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleFrom enrollment to the end of treatment at 4 weeksThe Visual Analog Scale (VAS) is a tool for measuring subjective experiences, like pain. It's typically a 10 cm line, with endpoints marking the extremes (e.g., no pain to worst imaginable pain). The minimum value is 0, and the maximum is 10. Respondents mark a point on the line that corresponds to their experience. Higher scores usually indicate worse outcomes for negative experiences like pain.
Range of motionFrom enrollment to the end of treatment at 4 weeksRange of motion (ROM) measures the movement extent of a joint or body part, expressed in degrees. Minimum values indicate restricted movement (e.g., 0° signifies no movement), while maximum values represent full movement capacity (e.g., 180° for shoulder flexion). Higher scores generally indicate a better outcome, as they reflect greater flexibility and joint function.
Shoulder Pain and Disability IndexFrom enrollment to the end of treatment at 4 weeksThe Shoulder Pain and Disability Index (SPADI) is a 13-item questionnaire assessing pain and disability due to shoulder issues. Scores range from 0 to 100, with 0 indicating no pain/disability and 100 indicating severe pain/disability. Higher scores signify worse outcomes, reflecting greater pain and functional impairment.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026